Comprehensive Analysis of Iron Deficiency Anemia and Its Related Disorders in Premenopausal Women Based on a Propensity Score Matching Case Control Study Using National Health Insurance Service Database in Korea.
Adenomyosis
Anemia
Gastrointestinal Malignancies
Iron-Deficiency
Leiomyoma of Uterus
Journal
Journal of Korean medical science
ISSN: 1598-6357
Titre abrégé: J Korean Med Sci
Pays: Korea (South)
ID NLM: 8703518
Informations de publication
Date de publication:
18 Sep 2023
18 Sep 2023
Historique:
received:
31
01
2023
accepted:
25
06
2023
medline:
20
9
2023
pubmed:
19
9
2023
entrez:
19
9
2023
Statut:
epublish
Résumé
Menorrhagia is a common cause of iron deficiency anemia (IDA) in premenopausal women. However, the effects of menorrhagia on IDA in premenopausal women have been underestimated compared to those on other IDA-related disorders (IRDs) such as gastrointestinal malignancies (GIMs). To better understand the relationship between menorrhagia and IDA in premenopausal women, we analyzed the National Health Insurance Service-National Health Information Database (NHIS-NHID). From 2005 to 2008, data about women between the age of 20 and 59 years were extracted from the NHIS-NHID to create a propensity score-matched case (IDA) and control group. The annual incidence of IDA was calculated per age group. A 10-year follow up of the study population was determined to detect IRDs in case and control groups. We compared the risk of detection (ROD) of IRDs, including GIM and gynecological disorders associated with menorrhagia - leiomyoma of uterus (LM) and adenomyosis (AM), in the case and the control group. From 2005 to 2008, women diagnosed with IDA (n = 535,249) and healthy women as a control group (n = 1,070,498) were identified from the NHIS-NHID. The annual incidence of IDA was 767.4 (2005), 948.7 (2006), 981.6 (2007), and 897.7 (2008) per 100,000 women. The age distribution of IDA was similar each year; IDA was common in women aged 30-39 years (36-37%) and 40-49 years (30-32%), and its incidence was significantly decreased in women aged 50-59 years (< 10%). The ROD of IRDs were significantly higher in the IDA group than in the control group (LM: 20.8% vs. 6.9%, AM: 5.6% vs. 1.6%, and GIM: 2.6% vs. 0.7%). The corresponding hazard ratios were 3.89 (95% confidence interval [CI], 3.85-3.93) for LM, 4.99 (95% CI, 4.90-5.09) for AM, and 3.43 (95% CI, 3.32-3.55) for GIM. The ROD of the IRDs varied; the ROD of LM in the IDA group increased with age and decreased in the age group 50-59 years. AM was more frequently detected in women with IDA aged 30-39 years and less in women older than 40 years. The frequency of GIM increased with age. In this study, we found that the gynecologic disease is the main cause of IDA in premenopausal women. Gynecological evaluations should be performed more actively in the clinic to prevent and control IDA and IRDs.
Sections du résumé
BACKGROUND
BACKGROUND
Menorrhagia is a common cause of iron deficiency anemia (IDA) in premenopausal women. However, the effects of menorrhagia on IDA in premenopausal women have been underestimated compared to those on other IDA-related disorders (IRDs) such as gastrointestinal malignancies (GIMs). To better understand the relationship between menorrhagia and IDA in premenopausal women, we analyzed the National Health Insurance Service-National Health Information Database (NHIS-NHID).
METHODS
METHODS
From 2005 to 2008, data about women between the age of 20 and 59 years were extracted from the NHIS-NHID to create a propensity score-matched case (IDA) and control group. The annual incidence of IDA was calculated per age group. A 10-year follow up of the study population was determined to detect IRDs in case and control groups. We compared the risk of detection (ROD) of IRDs, including GIM and gynecological disorders associated with menorrhagia - leiomyoma of uterus (LM) and adenomyosis (AM), in the case and the control group.
RESULTS
RESULTS
From 2005 to 2008, women diagnosed with IDA (n = 535,249) and healthy women as a control group (n = 1,070,498) were identified from the NHIS-NHID. The annual incidence of IDA was 767.4 (2005), 948.7 (2006), 981.6 (2007), and 897.7 (2008) per 100,000 women. The age distribution of IDA was similar each year; IDA was common in women aged 30-39 years (36-37%) and 40-49 years (30-32%), and its incidence was significantly decreased in women aged 50-59 years (< 10%). The ROD of IRDs were significantly higher in the IDA group than in the control group (LM: 20.8% vs. 6.9%, AM: 5.6% vs. 1.6%, and GIM: 2.6% vs. 0.7%). The corresponding hazard ratios were 3.89 (95% confidence interval [CI], 3.85-3.93) for LM, 4.99 (95% CI, 4.90-5.09) for AM, and 3.43 (95% CI, 3.32-3.55) for GIM. The ROD of the IRDs varied; the ROD of LM in the IDA group increased with age and decreased in the age group 50-59 years. AM was more frequently detected in women with IDA aged 30-39 years and less in women older than 40 years. The frequency of GIM increased with age.
CONCLUSION
CONCLUSIONS
In this study, we found that the gynecologic disease is the main cause of IDA in premenopausal women. Gynecological evaluations should be performed more actively in the clinic to prevent and control IDA and IRDs.
Identifiants
pubmed: 37724497
pii: 38.e299
doi: 10.3346/jkms.2023.38.e299
pmc: PMC10506900
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e299Subventions
Organisme : National Health Insurance Ilsan Hospital
ID : 2019-20-024
Pays : Korea
Informations de copyright
© 2023 The Korean Academy of Medical Sciences.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
Am J Clin Nutr. 2000 May;71(5 Suppl):1280S-4S
pubmed: 10799402
J Nutr. 2001 Feb;131(2S-2):676S-688S; discussion 688S-690S
pubmed: 11160598
Am J Hum Biol. 2006 Sep-Oct;18(5):710-3
pubmed: 16917885
N Engl J Med. 2015 Jul 30;373(5):485-6
pubmed: 26222573
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):152-159
pubmed: 29222250
Obstet Gynecol Sci. 2017 Nov;60(6):579-586
pubmed: 29184867
Am J Gastroenterol. 1999 Jan;94(1):109-15
pubmed: 9934740
Blood Res. 2013 Mar;48(1):46-50
pubmed: 23589795
J Minim Invasive Gynecol. 2011 Jul-Aug;18(4):428-37
pubmed: 21622029
J Womens Health (Larchmt). 2021 Jul;30(7):1038-1046
pubmed: 32991229
J Korean Med Sci. 2014 Feb;29(2):224-9
pubmed: 24550649
Blood Rev. 2006 Jul;20(4):213-26
pubmed: 16472893
Int J Epidemiol. 2017 Jun 1;46(3):799-800
pubmed: 27794523
Cancer Res Treat. 2022 Apr;54(2):330-344
pubmed: 35313102
Lancet Glob Health. 2013 Jul;1(1):e16-25
pubmed: 25103581
Pediatrics. 2010 Aug;126(2):e427-34
pubmed: 20660551
Int J Fertil Steril. 2016 Jan-Mar;9(4):424-35
pubmed: 26985330
Blood. 2014 Jan 30;123(5):615-24
pubmed: 24297872